
Mitant 50mg Capsule
Marketer
Hetero Healthcare Limited
Salt Composition
Sunitinib (50mg)
Overview Mitant 50mg Capsule
Oncaspar 50mg capsules are indicated for kidney cancer and gastrointestinal stromal tumor treatment. Their mechanism involves inhibiting specific enzymes crucial for cancer cell proliferation, thereby reducing tumor size and growth rate. Oncaspar 50mg capsules may be administered with or without food, but consistent daily timing optimizes efficacy. Dosage and frequency are determined by your physician, based on your condition and may be adjusted. Strict adherence to the prescribed regimen is vital, as incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include fatigue, diarrhea, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring may be advised. Hypoglycemia, potentially severe enough to cause syncope, is possible; diabetics should monitor blood glucose closely and discuss potential anti-diabetic medication adjustments with their doctor. Prior to commencing treatment, disclose any pre-existing heart, liver, kidney, or bleeding disorders. Inform your healthcare provider of all concurrent medications due to potential interactions. This medication is contraindicated during pregnancy and lactation; effective contraception is mandatory for both partners throughout treatment.
Uses of Mitant 50mg Capsule
Kidney and gastrointestinal stromal tumor therapies
Major Benefits of Mitant 50mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Mitant 50mg Capsules can be ingested with or without food; however, consistent timing is recommended.
Common Side effects of Mitant 50mg Capsule:
- Hand-foot syndrome
- Bleeding disorder
- Low blood platelets
- Decreased appetite
- Nausea
- Vomiting
- Weakness
- Abdominal pain
- Indigestion
- High blood pressure
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Taste change
How to use Mitant 50mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Mitant 50mg Capsules can be ingested with or without food, although consistent timing is recommended.
How Mitant 50mg Capsule works:
Mitant 50mg capsules are an anticancer drug that inhibits the activity of tyrosine kinase, a cell-surface protein crucial for cancer cell growth. By targeting this protein, the drug halts tumor expansion and angiogenesis (new blood vessel formation), thereby suppressing malignant cancer proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Mitant 50mg Capsule is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Mitant 50mg Capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Mitant 50mg Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Mitant 50mg Capsules, which can induce dizziness. Refrain from driving or operating machinery if dizziness occurs during treatment.
KidneySAFE IF PRESCRIBED
Mitant 50mg capsules pose no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Mitant 50mg capsules pose no safety concerns for individuals with hepatic impairment. Dosage modification for Mitant 50mg capsules is unnecessary.
What if you forget to take Mitant 50mg Capsule :
Omit any missed Mitant 50mg Capsule and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mitant 50mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Indole and Pyrrole-Based Compounds |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
